LAVA Therapeutics N.V. - stock earnings
LVTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -8.8 million USD | 53000 USD |
| 2023Q2 | -12.7 million USD | 5.1 million USD |
| 2023Q1 | -15.0 million USD | 2.6 million USD |
| 2022Q4 | -15.0 million USD | 2.6 million USD |
| 2022Q3 | 936000 USD | 15.3 million USD |
| 2022Q2 | -7.9 million USD | 468000 USD |
| 2022Q1 | -10.6 million USD | 1.0 million USD |
| 2021Q4 | -9.9 million USD | 1.0 million USD |
| 2021Q3 | -8.7 million USD | 2.1 million USD |
| 2021Q2 | -6.9 million USD | 1.1 million USD |
| 2021Q1 | -19.4 million USD | 1.1 million USD |
| 2020Q4 | -4.4 million USD | 2.3 million USD |
| 2020Q3 | -3.9 million USD | 970942 USD |
| 2020Q2 | -3.9 million USD | 665804 USD |
| 2020Q1 | -4.1 million USD | ? USD |
| 2019Q3 | -2.2 million USD | ? USD |
| 2019Q2 | -2.2 million USD | ? USD |
| 2019Q1 | -2.2 million USD | ? USD |
| 2018Q4 | -2.2 million USD | ? USD |
LVTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -50.4 million USD | 9.1 million USD |
| 2022 | -31.9 million USD | 19.4 million USD |
| 2021 | -45.3 million USD | 5.0 million USD |
| 2020 | -16.7 million USD | 3.9 million USD |
| 2019 | -9.8 million USD | ? USD |
LVTX
Price: $2.73
52 week price:
Earnings Per Share: -1.57 USD
P/E Ratio: -0.90
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 12191
Market Capitalization: 81.8 million